Universe Pharmaceuticals (UPC) Accounts Payables (2021 - 2025)

Universe Pharmaceuticals has disclosed Accounts Payables across 5 years of filings, most recently posting $262.6 million for Q3 2025.

• Accounts Payables for Q3 2025 came in at $262.6 million, down 25.57% year-over-year; the trailing twelve-month figure through Sep 2025 was $262.6 million (down 25.57% YoY), and the FY2025 annual result was $262.6 million, down 25.57% from the prior year.
• Accounts Payables came in at $262.6 million for Q3 2025 at Universe Pharmaceuticals, down from $352.9 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $352.9 million in Q3 2024 to a low of $3.1 million in Q3 2022.
• The 5-year median for Accounts Payables is $5.3 million (2021), against an average of $125.7 million.
• Across the five-year window, Accounts Payables slumped 42.09% in 2022 and jumped 7595.36% in 2024, its largest moves.
• Universe Pharmaceuticals' Accounts Payables stood at $5.3 million in 2021, then plunged by 42.09% to $3.1 million in 2022, then surged by 49.1% to $4.6 million in 2023, then surged by 7595.36% to $352.9 million in 2024, then dropped by 25.57% to $262.6 million in 2025.
• The last three Accounts Payables figures came in at $262.6 million (Q3 2025), $352.9 million (Q3 2024), and $4.6 million (Q3 2023), per Business Quant data.